T Cell Malignancies
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs) (NCT07465835) | Electra Therapeutics Inc. | 2026-02-17 |
| A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies (NCT07070323) | Beijing GoBroad Hospital | 2025-07-09 |
| CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies (NCT06316856) | Beijing GoBroad Hospital | 2024-06-18 |
| Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies (NCT06316427) | Beijing GoBroad Hospital | 2024-03-22 |
Track T Cell Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.